Clinical trial
Melatonin in Improving the Quality of Life of Breast Cancer Patients and Reduction of Postoperative Pain and Chemotherapy Induced Toxicity
NCT01557478 is registered in ClinicalTrials.gov with Khon Kaen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Melatonin in Improving the Quality of Life of Breast Cancer Patients and Reduction of Postoperative Pain and Chemotherapy Induced Toxicity
- Lead sponsor
- Khon Kaen University
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- March 31, 2012
- Completion date
- Not reported
- Enrollment
- 166 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
stage ii and iii breast cancer